Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology
Journal of Clinical Investigation · 17.11.2025 · 135 (22)
DOI: 10.1172/jci194727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.09.2025. Verfasst von Arnab Bose und 19 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Human Biology and. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Genomic Instability, Transcriptome, Neoplasm Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, CDMRP.
Abstract (Originalsprache)
A cornerstone of research to improve cancer outcomes involves studies of model systems to identify causal drivers of oncogenesis, understand mechanisms leading to metastases, and develop new therapeutics. Although most cancer types are represented by large cell line panels that reflect diverse neoplastic genotypes and phenotypes found in patients, prostate cancer is notable for a very limited repertoire of models that recapitulate the pathobiology of human disease. Of these, the lymph node carcinoma of the prostate (LNCaP) cell line has served as the major resource for basic and translational studies. Here, we delineated the molecular composition of LNCaP and multiple substrains through analyses of whole-genome sequences, transcriptomes, chromatin structure, androgen receptor (AR) cistromes, and functional studies. Our results determined that LNCaP exhibits substantial subclonal diversity, ongoing genomic instability, and phenotype plasticity. Several oncogenic features were consistently present across strains, but others were unexpectedly variable, such as ETV1 expression, Y chromosome loss, a reliance on WNT and glucocorticoid receptor activity, and distinct AR alterations maintaining AR pathway activation. These results document the inherent molecular heterogeneity and ongoing genomic instability that drive diverse prostate cancer phenotypes and provide a foundation for the accurate interpretation and reproduction of research findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divisions of Human Biology and.
- Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
- CDMRP
Zitieren
APA
Bose, A., Bankhead, A., Coleman, I., Persse, T., Han, W., Galipeau, P., Hanratty, B., Chu, T., Lucas, J., Li, D., Bilkis, R., Itagi, P., Hassan, S., Beightol, M., Ko, M., Dumpit, R., Haffner, M., Pritchard, C., Ha, G., & Nelson, P. S. (2025). Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology. Journal of Clinical Investigation, 135(22). https://doi.org/10.1172/jci194727
Vancouver
Bose A, Bankhead A, Coleman I, Persse T, Han W, Galipeau P, et al. Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology. Journal of Clinical Investigation. 2025;135(22). doi:10.1172/jci194727
BibTeX
@article{Bose2025,
author = {Bose, Arnab and Bankhead, Armand and Coleman, Ilsa and Persse, Thomas and Han, Wanting and Galipeau, Patricia and Hanratty, Brian and Chu, Tony and Lucas, Jared and Li, Dapei and Bilkis, Rabeya and Itagi, Pushpa and Hassan, Sajida and Beightol, Mallory and Ko, Minjeong and Dumpit, Ruth and Haffner, Michael and Pritchard, Colin and Ha, Gavin and Nelson, Peter S},
title = {Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {22},
doi = {10.1172/jci194727}
}
EUVIMED